Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
recombinant ectodysplasin A1 (APO200) / Valerio Therap, Pierre Fabre
EDELIFE, NCT04980638 / 2021-002532-23: Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia	Recruiting	2	20	Europe, US	ER004	EspeRare Foundation, Pierre Fabre Medicament, Iqvia Pty Ltd	X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)	04/25	01/29
ECP-002e, NCT01992289 / 2013-004565-14: Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002	Active, not recruiting	N/A	10	US, Europe	EDI200, APO200	Edimer Pharmaceuticals	X-linked Hypohidrotic Ectodermal Dysplasia	03/25	03/25